JP Patent

JP5031054B2 — 低置換度ヒドロキシプロピルセルロース及びこれを含む固形製剤

Assigned to Shin Etsu Chemical Co Ltd · Expires 2012-09-19 · 14y expired

What this patent protects

Patent listed against Tradjenta.

Drugs covered by this patent

Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim

Patent Metadata

Patent number: JP5031054B2
Jurisdiction: JP
Classification: —
Expires: 2012-09-19
Drug substance claim: No
Drug product claim: No
Assignee: Shin Etsu Chemical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.